Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method

Publié en ligne: 31 déc. 2020

Pages: 415 - 428

Accepté: 04 août 2020

DOI: https://doi.org/10.2478/acph-2021-0024

Mots clés

ZCJ14, epidermal growth factor receptor inhibitor, LC-MS/MS, pharmacokinetics, bioavailability

© 2021 Sai-Jie Zuo et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.